Boehringer Ingelheim

Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Motley Fool
Tue, 03/26/13 - 09:20 am
diabetes
FDA
Eli Lilly
Boehringer Ingelheim
empagliflozin
Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta® (linagliptin) tablets in patients with type 2 diabetes and albuminuria
Yahoo
Tue, 03/19/13 - 10:43 am
Eli Lilly
Boehringer Ingelheim
Tradjenta
diabetes
albuminuria
Boehringer signs hep C pact with Presidio
Pharma Times, UK
Thu, 03/14/13 - 10:56 am
hepatitis C
Presidio Pharmaceuticals
Boehringer Ingelheim
Boehringer Lung Drug Wins U.S. FDA Advisory Panel Backing
Bloomberg
Wed, 01/30/13 - 10:59 am
FDA
COPD
Boehringer Ingelheim
olodaterol
Boehringer Testing Copy of Rituxan in Type of Lymphoma
Bloomberg
Wed, 01/30/13 - 10:57 am
Rituxan
Boehringer Ingelheim
Roche
non-Hodgkin's lymphoma
Boehringer’s Lung Drug’s Benefits Questioned
Bloomberg
Fri, 01/25/13 - 10:08 am
Boehringer Ingelheim
olodaterol
COPD
FDA fast tracks two new lung cancer drugs
PM Live
Fri, 01/18/13 - 10:17 am
fast track
FDA
Boehringer Ingelheim
Astellas
Roche
Afatinib
Tarceva
non-small cell lung cancer
BI's cancer drug afatinib gets US fast-track review
Pharma Times, UK
Wed, 01/16/13 - 08:38 am
Afatinib
Boehringer Ingelheim
fast track
non-small cell lung cancer
Boehringer Ingelheim to initiate Phase III study in leukemia with its compound volasertib* based on positive Phase II results
Pipeline Review
Tue, 12/11/12 - 11:31 am
Boehringer Ingelheim
leukemia
volasertib
AML
acute myeloid leukemia
Boehringer Sued by Hundreds Over Bleeding Tied to Pradaxa
Bloomberg
Tue, 12/11/12 - 10:17 am
Boehringer Ingelheim
Pradaxa
Boehringer, Ensemble join forces to discover macrocycle drugs
Pharmaceutical Business Review
Fri, 11/2/12 - 10:03 am
Boehringer Ingelheim
R&D
contract research
macrocycle drugs
Ensemble Therapeutics
European approval granted for Trajenta tablets as add-on therapy in Diabetes
Yahoo/Fly on the Wall
Fri, 10/26/12 - 11:12 am
Europe
Trajents
diabetes
Eli Lilly
Boehringer Ingelheim
Drugmaker Boehringer settles marketing claim for $95 mln
Reuters
Thu, 10/25/12 - 05:35 pm
Boehringer Ingelheim
Aggrenox
off-label
Micardis
Combivent
Atrovent
Lilly Backs Broad Diabetes Range to Challenge Rivals
Bloomberg
Mon, 10/8/12 - 12:53 pm
Eli Lilly
diabetes
Boehringer Ingelheim
Amylin
LY2605541
GLP-1 agonist
SGLT2 inhibitor
Roche Faces New Foe as Boehringer Plans a Rituxan Copy
Bloomberg
Fri, 10/5/12 - 11:27 am
Roche
Rituxan
Boehringer Ingelheim
rheumatoid arthritis
How Many Pharmas Does It Take to Accelerate Drug Development?
Motley Fool
Tue, 09/25/12 - 10:04 am
drug development
Abbott Labs
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Pfizer
Roche
Sanofi
TransCelerate BioPharma
FDA: Boehringer Parkinson's med may boost heart failure risk
Fierce Pharma
Thu, 09/20/12 - 12:05 pm
FDA
Boehringer Ingelheim
Parkinson's Disease
Mirapex
10 drugmakers team up to improve testing process
Yahoo/AP
Thu, 09/20/12 - 10:38 am
TransCelerate BioPharma
Pfizer
JNJ
Bristol-Myers Squibb
Eli Lilly
Abbott Laboratories
GSK
AstraZeneca
Sanofi
Boehringer Ingelheim
Genentech
Boehringer Ingelheim lets Facebook game loose
Fierce Pharma
Fri, 09/14/12 - 11:54 am
Boehringer Ingelheim
social media
Facebook
Syrum
JAMA says FDA jumped the gun on Gilenya, Pradaxa
Fierce Pharma
Thu, 09/6/12 - 09:33 am
JAMA
FDA
Pradaxa
Gilenya
Caprelsa
Boehringer Ingelheim
Novartis
AstraZeneca

Pages